Share on StockTwits

Research analysts at Leerink Swann boosted their price objective on shares of CVS Caremark (NYSE:CVS) from $85.00 to $87.00 in a report released on Wednesday. Leerink Swann’s target price would suggest a potential upside of 12.94% from the stock’s previous close.

CVS has been the subject of a number of other recent research reports. Analysts at Argus raised their price target on shares of CVS Caremark from $83.00 to $85.00 in a research note on Wednesday. They now have a “buy” rating on the stock. Separately, analysts at RBC Capital raised their price target on shares of CVS Caremark from $76.00 to $86.00 in a research note on Wednesday. They now have an “outperform” rating on the stock. Finally, analysts at Mizuho raised their price target on shares of CVS Caremark from $81.00 to $85.00 in a research note on Wednesday. They now have a “buy” rating on the stock. One analyst has rated the stock with a sell rating, three have given a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. CVS Caremark has an average rating of “Buy” and an average price target of $80.48.

CVS Caremark (NYSE:CVS) traded down 0.31% on Wednesday, hitting $77.03. The stock had a trading volume of 11,306,321 shares. CVS Caremark has a one year low of $56.32 and a one year high of $79.43. The stock has a 50-day moving average of $76.91 and a 200-day moving average of $74.23. The company has a market cap of $90.356 billion and a price-to-earnings ratio of 19.68. CVS Caremark also was the recipient of some unusual options trading activity on Monday. Stock traders acquired 7,359 put options on the stock. This represents an increase of approximately 776% compared to the average volume of 840 put options.

CVS Caremark (NYSE:CVS) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $1.13 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.10 by $0.03. The company had revenue of $34.60 billion for the quarter, compared to the consensus estimate of $33.47 billion. During the same quarter last year, the company posted $0.97 earnings per share. CVS Caremark’s revenue was up 10.7% compared to the same quarter last year. Analysts expect that CVS Caremark will post $4.47 EPS for the current fiscal year.

CVS Caremark Corporation (NYSE:CVS), together with its subsidiaries, is a pharmacy health care provider in the United States.

Receive News & Ratings for CVS Caremark Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Caremark Co and related companies with Analyst Ratings Network's FREE daily email newsletter.